Efficacy and Safety of Recombinant Human Insulin Patch ZJSRM2021
Status:
Not yet recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to investigate the efficacy，safety， and tolerability of the
recombinant human insulin patch ZJSRM2021 in healthy subjects, type 1diabetes mellitus and
type 2diabetes mellitus patients